Glioma: molecular signature and crossroads with tumor microenvironment
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glioma: molecular signature and crossroads with tumor microenvironment
Authors
Keywords
-
Journal
CANCER AND METASTASIS REVIEWS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-10-23
DOI
10.1007/s10555-021-09997-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Current Immunotherapies for Glioblastoma Multiforme
- (2021) Boyuan Huang et al. Frontiers in Immunology
- The Many Facets of Therapy Resistance and Tumor Recurrence in Glioblastoma
- (2021) Anshika Goenka et al. Cells
- Molecular and Clinicopathological Characterization of a Prognostic Immune Gene Signature Associated With MGMT Methylation in Glioblastoma
- (2021) Liang Zhao et al. Frontiers in Cell and Developmental Biology
- A vaccine targeting mutant IDH1 in newly diagnosed glioma
- (2021) Michael Platten et al. NATURE
- Hypoxic glioma-derived exosomes promote M2-like macrophage polarization by enhancing autophagy induction
- (2021) Jianye Xu et al. Cell Death & Disease
- Is there a causal link between PTEN deficient tumors and immunosuppressive tumor microenvironment?
- (2020) Vildan B. Cetintas et al. Journal of Translational Medicine
- EGFRvIII upregulates DNA mismatch repair resulting in increased temozolomide sensitivity of MGMT promoter methylated glioblastoma
- (2020) Nina Struve et al. ONCOGENE
- Extracellular Vesicles in Glioblastoma Tumor Microenvironment
- (2020) Anuroop Yekula et al. Frontiers in Immunology
- An Update on Neurofibromatosis Type 1-Associated Gliomas
- (2020) Lobbous et al. Cancers
- CCL2/CCR2 signaling in cancer pathogenesis
- (2020) Qiongyu Hao et al. Cell Communication and Signaling
- Breaking through the glioblastoma micro-environment via extracellular vesicles
- (2020) Thomas Simon et al. ONCOGENE
- Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma
- (2020) David A. Reardon et al. JAMA Oncology
- Hypoxia Inducible Factors’ Signaling in Pediatric High-Grade Gliomas: Role, Modelization and Innovative Targeted Approaches
- (2020) Quentin Fuchs et al. Cancers
- The CXCL12/CXCR4 axis confers temozolomide resistance to human glioblastoma cells via up-regulation of FOXM1
- (2020) Shengwen Wang et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- IL1RAP regulated by PRPRD promotes gliomas progression via inducing neuronal synapse development and neuron differentiation in vitro
- (2020) Feng Li et al. PATHOLOGY RESEARCH AND PRACTICE
- MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas
- (2020) Barbara Oldrini et al. Nature Communications
- Molecular subtyping of glioblastoma based on immune-related genes for prognosis
- (2020) Xueran Chen et al. Scientific Reports
- Identification of Immune Cell Infiltration and Immune-Related Genes in the Tumor Microenvironment of Glioblastomas
- (2020) Sicong Huang et al. Frontiers in Immunology
- EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
- (2020) Michael Weller et al. Nature Reviews Clinical Oncology
- Role of Notch Signaling Pathway in Glioblastoma Multiforme Pathogenesis
- (2019) Riccardo Bazzoni et al. Cancers
- The immune suppressive microenvironment of human gliomas depends on the accumulation of bone marrow-derived macrophages in the center of the lesion
- (2019) Laura Pinton et al. Journal for ImmunoTherapy of Cancer
- (R)-2-hydroxyglutarate drives immune quiescence in the tumor microenvironment of IDH-mutant gliomas
- (2019) Leland G. Richardson et al. Translational Cancer Research
- Interleukin-8/CXCR2 signaling regulates therapy-induced plasticity and enhances tumorigenicity in glioblastoma
- (2019) Tanwir Hasan et al. Cell Death & Disease
- Current State of Immunotherapy for Treatment of Glioblastoma
- (2019) Tresa McGranahan et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Glioblastoma-Derived IL-6 Induces Immunosuppressive Peripheral Myeloid Cell PD-L1 and Promotes Tumor Growth
- (2019) Jonathan B Lamano et al. CLINICAL CANCER RESEARCH
- The landscape of the mesenchymal signature in brain tumours
- (2019) Jinan Behnan et al. BRAIN
- Glioblastoma heterogeneity and the tumour microenvironment: implications for preclinical research and development of new treatments
- (2019) Sally L. Perrin et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Glutamate Receptors and Glioblastoma Multiforme: An Old “Route” for New Perspectives
- (2019) Lorenzo Corsi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Design of a brain-penetrant CDK4/6 inhibitor for glioblastoma
- (2019) Sarah M. Bronner et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Symbiotic Macrophage-Glioma Cell Interactions Reveal Synthetic Lethality in PTEN-Null Glioma
- (2019) Peiwen Chen et al. CANCER CELL
- Macrophages and Metabolism in the Tumor Microenvironment
- (2019) Ilio Vitale et al. Cell Metabolism
- Integrins as biomechanical sensors of the microenvironment
- (2019) Jenny Z. Kechagia et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- PI3K/mTOR inhibition of IDH1 mutant glioma leads to reduced 2HG production that is associated with increased survival
- (2019) Georgios Batsios et al. Scientific Reports
- Oncogenic BRAF Alterations and Their Role in Brain Tumors
- (2019) Felix Behling et al. Cancers
- Interleukin-8 Secreted by Glioblastoma Cells Induces Microvascular Hyperpermeability Through NO Signaling Involving S-Nitrosylation of VE-Cadherin and p120 in Endothelial Cells
- (2019) Anita Guequén et al. Frontiers in Physiology
- Microenvironmental Heterogeneity in Brain Malignancies
- (2019) Lucas J. M. Perus et al. Frontiers in Immunology
- The Multifaceted p21 (Cip1/Waf1/CDKN1A) in Cell Differentiation, Migration and Cancer Therapy
- (2019) Kreis et al. Cancers
- WNT Signaling in Disease
- (2019) Ng et al. Cells
- The Acidic Tumor Microenvironment as a Driver of Cancer
- (2019) Ebbe Boedtkjer et al. Annual Review of Physiology
- Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation
- (2019) Cheila Brito et al. BMC CANCER
- p53 Isoforms in Cellular Senescence- and Ageing-Associated Biological and Physiological Functions
- (2019) Kaori Fujita INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- PD-L1/PD-1 Axis in Glioblastoma Multiforme
- (2019) Jakub Litak et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- IMMU-34. ATRX MUTATIONS PREDICT RESPONSE TO INNATE BASED THERAPY IN GLIOMA
- (2019) Michelle Bowie et al. NEURO-ONCOLOGY
- Revising PTEN in the Era of Immunotherapy: New Perspectives for an Old Story
- (2019) Geny Piro et al. Cancers
- Nuclear Factor Kappa B Signaling Complexes in Acute Inflammation
- (2019) Sergio Rius-Pérez et al. ANTIOXIDANTS & REDOX SIGNALING
- EGFR mutation: novel prognostic factor associated with immune infiltration in lower-grade glioma; an exploratory study
- (2019) Zhaonian Hao et al. BMC CANCER
- Expression of Alpha-type Platelet-derived Growth Factor Receptor–influenced Genes Predicts Clinical Outcome in Glioma
- (2019) Eun-A Ko et al. Translational Oncology
- Reconstructing the molecular life history of gliomas
- (2018) Floris P. Barthel et al. ACTA NEUROPATHOLOGICA
- TP53 gain-of-function mutation promotes inflammation in glioblastoma
- (2018) Seok Won Ham et al. CELL DEATH AND DIFFERENTIATION
- Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
- (2018) Frederick F. Lang et al. JOURNAL OF CLINICAL ONCOLOGY
- First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
- (2018) Linda M. Liau et al. Journal of Translational Medicine
- The impact of oncogenic EGFRvIII on the proteome of extracellular vesicles released from glioblastoma cells
- (2018) Dongsic Choi et al. MOLECULAR & CELLULAR PROTEOMICS
- Current Challenges and Opportunities in Treating Glioblastoma
- (2018) Andrea Shergalis et al. PHARMACOLOGICAL REVIEWS
- An anatomic transcriptional atlas of human glioblastoma
- (2018) Ralph B. Puchalski et al. SCIENCE
- Non-Cell Autonomous Effects of the Senescence-Associated Secretory Phenotype in Cancer Therapy
- (2018) Tareq Saleh et al. Frontiers in Oncology
- The role of interleukin‑6‑STAT3 signalling in glioblastoma (Review)
- (2018) Alice West et al. Oncology Letters
- The p53 Pathway in Glioblastoma
- (2018) Ying Zhang et al. Cancers
- EGFR Cooperates with EGFRvIII to Recruit Macrophages in Glioblastoma
- (2018) Zhenyi An et al. CANCER RESEARCH
- Epidermal growth factor receptor promotes glioma progression by regulating xCT and GluN2B-containing N -methyl-d -aspartate-sensitive glutamate receptor signaling
- (2018) Kentaro Suina et al. CANCER SCIENCE
- Extracellular Vesicles Released by Glioblastoma Cells Stimulate Normal Astrocytes to Acquire a Tumor-Supportive Phenotype Via p53 and MYC Signaling Pathways
- (2018) S. Hallal et al. MOLECULAR NEUROBIOLOGY
- The molecular landscape of glioma in patients with Neurofibromatosis 1
- (2018) Fulvio D’Angelo et al. NATURE MEDICINE
- KIAA1549-BRAF Expression Establishes a Permissive Tumor Microenvironment Through NFκB-Mediated CCL2 Production
- (2018) Ran Chen et al. NEOPLASIA
- Glioblastoma cellular cross-talk converges on NF-κB to attenuate EGFR inhibitor sensitivity
- (2017) Ciro Zanca et al. GENES & DEVELOPMENT
- The Molecular and Phenotypic Basis of the Glioma Invasive Perivascular Niche
- (2017) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Overcoming therapeutic resistance in glioblastoma: the way forward
- (2017) Satoru Osuka et al. JOURNAL OF CLINICAL INVESTIGATION
- A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients
- (2017) Susana Inogés et al. Journal of Translational Medicine
- Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
- (2017) Michael Weller et al. LANCET ONCOLOGY
- Detection of wild-type EGFR amplification and EGFRvIII mutation in CSF-derived extracellular vesicles of glioblastoma patients
- (2017) Javier M Figueroa et al. NEURO-ONCOLOGY
- Correlation of immune phenotype with IDH mutation in diffuse glioma
- (2017) Anna Sophie Berghoff et al. NEURO-ONCOLOGY
- HER2-Specific Chimeric Antigen Receptor–Modified Virus-Specific T Cells for Progressive Glioblastoma
- (2017) Nabil Ahmed et al. JAMA Oncology
- The Role of ATRX in Glioma Biology
- (2017) Pravanya Nandakumar et al. Frontiers in Oncology
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Clinical study of a survivin long peptide vaccine (SurVaxM) in patients with recurrent malignant glioma
- (2016) Robert A. Fenstermaker et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The EGF Receptor Promotes the Malignant Potential of Glioma by Regulating Amino Acid Transport System xc(--)
- (2016) K. Tsuchihashi et al. CANCER RESEARCH
- Vaccination with Irradiated Autologous Tumor Cells Mixed with Irradiated GM-K562 Cells Stimulates Antitumor Immunity and T Lymphocyte Activation in Patients with Recurrent Malignant Glioma
- (2016) W. T. Curry et al. CLINICAL CANCER RESEARCH
- A Cancer Research UK First Time in Human Phase I Trial of IMA950 (Novel Multipeptide Therapeutic Vaccine) in Patients with Newly Diagnosed Glioblastoma
- (2016) R. Rampling et al. CLINICAL CANCER RESEARCH
- Effect of tyrosine hydroxylase overexpression in lymphocytes on the differentiation and function of T helper cells
- (2016) Hui-Wei Huang et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Exploring the role of inflammation in the malignant transformation of low-grade gliomas
- (2016) Nicole Michelson et al. JOURNAL OF NEUROIMMUNOLOGY
- Decrease of VEGF-A in myeloid cells attenuates glioma progression and prolongs survival in an experimental glioma model
- (2016) Nadja Osterberg et al. NEURO-ONCOLOGY
- TMIC-14. TUMOR EVOLUTION OF GLIOMA INTRINSIC GENE EXPRESSION SUBTYPE ASSOCIATES WITH IMMUNOLOGICAL CHANGES IN THE MICROENVIRONMENT
- (2016) Qianghu Wang et al. NEURO-ONCOLOGY
- Bioinformatic profiling identifies an immune-related risk signature for glioblastoma
- (2016) Wen Cheng et al. NEUROLOGY
- Phase III randomized trial of autologous cytokine-induced killer cell immunotherapy for newly diagnosed glioblastoma in korea
- (2016) Doo-Sik Kong et al. Oncotarget
- Bioactivity and Safety of IL13R 2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
- (2015) C. E. Brown et al. CLINICAL CANCER RESEARCH
- Molecular Connections between Cancer Cell Metabolism and the Tumor Microenvironment
- (2015) Calvin Justus et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study
- (2015) J. Schuster et al. NEURO-ONCOLOGY
- Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance
- (2015) Malin Wickström et al. Nature Communications
- Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma
- (2015) Huilin Shao et al. Nature Communications
- Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy
- (2015) W. Peng et al. Cancer Discovery
- CDK4/6 Inhibitor PD0332991 in Glioblastoma Treatment: Does It Have a Future?
- (2015) Lisette B. W. Schröder et al. Frontiers in Oncology
- Autologous T-cell Therapy for Cytomegalovirus as a Consolidative Treatment for Recurrent Glioblastoma
- (2014) A. Schuessler et al. CANCER RESEARCH
- Caught in the cross fire: p53 in inflammation
- (2014) Tomer Cooks et al. CARCINOGENESIS
- Double-stranded DNA in exosomes: a novel biomarker in cancer detection
- (2014) Basant Kumar Thakur et al. CELL RESEARCH
- A Unified Nomenclature and Amino Acid Numbering for Human PTEN
- (2014) R. Pulido et al. Science Signaling
- Disruption of astrocyte–vascular coupling and the blood–brain barrier by invading glioma cells
- (2014) Stacey Watkins et al. Nature Communications
- Glioblastoma cells inhibit astrocytic p53-expression favoring cancer malignancy
- (2014) D Biasoli et al. Oncogenesis
- Extracellular Vesicles Modulate the Glioblastoma Microenvironment via a Tumor Suppression Signaling Network Directed by miR-1
- (2013) A. Bronisz et al. CANCER RESEARCH
- Non-Cell-Autonomous Tumor Suppression by p53
- (2013) Amaia Lujambio et al. CELL
- Glioblastoma Stem Cells Generate Vascular Pericytes to Support Vessel Function and Tumor Growth
- (2013) Lin Cheng et al. CELL
- IDH1 and IDH2 Mutations in Gliomas
- (2013) Adam L. Cohen et al. Current Neurology and Neuroscience Reports
- Heat-shock protein peptide complex–96 vaccination for recurrent glioblastoma: a phase II, single-arm trial
- (2013) Orin Bloch et al. NEURO-ONCOLOGY
- TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
- (2013) P. J. Killela et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Loss of Cell-Surface Laminin Anchoring Promotes Tumor Growth and Is Associated with Poor Clinical Outcomes
- (2012) A. Akhavan et al. CANCER RESEARCH
- p21WAF1 and tumourigenesis
- (2012) Noel A. Warfel et al. CURRENT OPINION IN ONCOLOGY
- Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial
- (2012) Kim Margolin et al. LANCET ONCOLOGY
- Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma
- (2011) Genevieve Schindler et al. ACTA NEUROPATHOLOGICA
- The oxidative stress-inducible cystine/glutamate antiporter, system x c − : cystine supplier and beyond
- (2011) Marcus Conrad et al. AMINO ACIDS
- Cyclin D1 and Cdk4 Mediate Development of Neurologically Destructive Oligodendroglioma
- (2011) D. Ciznadija et al. CANCER RESEARCH
- Clinical Stratification of Glioblastoma Based on Alterations in Retinoblastoma Tumor Suppressor Protein (RB1) and Association With the Proneural Subtype
- (2011) Patricia Goldhoff et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- EGFRvIII promotes glioma angiogenesis and growth through the NF-κB, interleukin-8 pathway
- (2011) R Bonavia et al. ONCOGENE
- Implications for immunotherapy of tumor-mediated T-cell apoptosis associated with loss of the tumor suppressor PTEN in glioblastoma
- (2010) James S. Waldron et al. JOURNAL OF CLINICAL NEUROSCIENCE
- IL-8 is a mediator of NF-κB induced invasion by gliomas
- (2010) Baisakhi Raychaudhuri et al. JOURNAL OF NEURO-ONCOLOGY
- Intratumoral Hypoxic Gradient Drives Stem Cells Distribution and MGMT Expression in Glioblastoma
- (2010) Francesca Pistollato et al. STEM CELLS
- Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma
- (2009) Andrey Korshunov et al. ACTA NEUROPATHOLOGICA
- Tumor initiating cells in malignant gliomas: biology and implications for therapy
- (2009) Costas G. Hadjipanayis et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells
- (2008) Khalid Al-Nedawi et al. NATURE CELL BIOLOGY
- Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers
- (2008) Johan Skog et al. NATURE CELL BIOLOGY
- CD133 Is a Marker of Bioenergetic Stress in Human Glioma
- (2008) Corinne E. Griguer et al. PLoS One
- Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor
- (2008) Jean-Philippe Coppé et al. PLOS BIOLOGY
- Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma
- (2007) Duane A. Mitchell et al. NEURO-ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search